학술논문

O3-2-1 - Avelumab in platinum-resistant/refractory ovarian cancer (PRROC): phase 3 results from JAVELIN Ovarian 200
Document Type
Abstract
Source
In Annals of Oncology October 2019 30 Supplement 6:vi89-vi89
Subject
Language
ISSN
0923-7534